← Back to Patent Explorer
US5260319A Expired / Lapsed US ⏱️ 0.0 years remaining

Thienobenzoxepins and naphthothiophenes

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1993-03-19
•
Granted: 1993-11-09
•
Expires: 2013-03-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel thienobenzoxepins and naphthothiophenes, intermediates and processes for the preparation thereof, and methods of alleviating pain utilizing compounds or compositions thereof are disclosed.

Inventors

  • 👤 Richard C. Effland
  • 👤 David G. Wettlaufer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 07:18
CPC Classifications
C; C07; C07D; C07D409/00; C07D409/02; C07D409/04; C07D409/06; C07D495/00; C07D495/02; C07D495/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 46 words
A compound of the formula ##STR6## wherein R is loweralkyl or arylloweralkyl; X and Y are independently hydrogen, loweralkyl, halogen, loweralkoxy, or trifluoromethyl; W is CH 2 , CHOH, or C═O; and n is 1 or 2; an optical isomer or pharmaceutically acceptable addition salt thereof.
Claim 2
Dependent Claim 46 words
A compound of the formula ##STR6## wherein R is loweralkyl or arylloweralkyl; X and Y are independently hydrogen, loweralkyl, halogen, loweralkoxy, or trifluoromethyl; W is CH 2 , CHOH, or C═O; and n is 1 or 2; an optical isomer or pharmaceutically acceptable addition salt thereof.
Claim 3
Dependent Claim 10 words
A compound according to claim 1 wherein n is 2.
Claim 4
Dependent Claim 9 words
The compound according to claim 2 which is (2-fluorophenyl)[3-[(1-methyl-4-piperidinyl)hydroxymethyl]-2-thienyl]methanone.
Claim 5
Dependent Claim 9 words
The compound according to claim 2 which is α-[2-[(2-fluorophenyl)methyl]-3-thienyl]-1-methyl-4-piperidinemethanol.
Claim 6
Dependent Claim 13 words
The compound according to claim 2 which is α 2 -(2-fluorophenyl)-α 3 -(1-methyl-4-piperidinyl)-2,3-thiophenedimethanol.
Claim 7
Dependent Claim 29 words
A method of alleviating pain in a mammal by administering to a mammal in need of pain alleviation a pain alleviating effect amount of a compound of claim 1.
Claim 8
Dependent Claim 20 words
A composition comprising a pain alleviating effective amount of a compound of claim 1 and a pharmaceutically acceptable adjuvant therefor.

References Cited (Backward Citations)

FR1371443A Cited
US4128641A Cited
US4025640A Cited
US4312868A Cited
US4294828A Cited
US4282365A Cited
EP0074304A1 Cited
EP0119541A1 Cited
US4595689A Cited
US5010087A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-11-08 1997-05-10 1997-11-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-11-08 2001-05-10 2001-11-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-11-08 2005-05-10 2005-11-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag